AI assistant
Sending…
Cardlytics, Inc. — Director's Dealing 2023
May 25, 2023
33956_dirs_2023-05-25_5cc38cec-fddc-46ac-aa6a-bfa78b13831e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2023-05-23
Reporting Person: Adams David Leslie (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-05-24 | Common Stock | M | 6465 | — | Acquired | 40514 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-05-23 | Restricted Stock Units | $ | A | 28547 | Acquired | Common Stock (28547) | Direct | |
| 2023-05-24 | Restricted Stock Units | $ | M | 6465 | Disposed | Common Stock (6465) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
F2: The RSUs shall vest in full on the one-year anniversary of the date of grant, provided that the Reporting Person remains a director of the Issuer on such vesting date.
F3: The RSUs vested in full on the one-year anniversary of the date of grant.
More from Cardlytics, Inc.
Delisting Announcement
2026
Jun 3
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Annual Report
2026
Mar 4
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 19